Results
1
Stocks where the price continues to rise after more than a year of consistent gains.
1 companies
Sareum Holdings
Market Cap: UK£40.2m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.37
7D
27.6%
1Y
76.2%